Center for Scientific Review; Notice of Closed Meetings, 2875-2876 [2016-00794]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
Development, Evaluation, and
Establishment of Specifications.’’ It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations.
III. Paperwork Reduction Act of 1995
This draft guidance refers to
previously approved collections of
information found in FDA regulations.
These collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR part 514 have
been approved under OMB control
number 0910–0032; the collections of
information in section 512(n)(1) of the
FD&C Act (21 U.S.C. 360k) have been
approved under OMB control number
0910–0669.
IV. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at either
https://www.fda.gov/AnimalVeterinary/
GuidanceComplianceEnforcement/
GuidanceforIndustry/default.htm or
https://www.regulations.gov.
Dated: January 13, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–00822 Filed 1–15–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Neuroscience.
Date: February 2–3, 2016.
Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biomedical Computing and Health
Informatics Study Section.
Date: February 5, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, 301–435–1116, kozelp@
mail.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Instrumentation and Systems
Development Study Section.
Date: February 10–11, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Best Western Tuscan Inn, 425 North
Point Street, San Francisco, CA 94133.
Contact Person: Kathryn Kalasinsky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158
MSC 7806, Bethesda, MD 20892, 301–402–
1074, kalasinskyks@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: February 10–11, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton San Diego Mission Valley,
901 Camino Del Rio South, San Diego, CA
92108.
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Motor Function, Speech and
Rehabilitation Study Section.
Date: February 11–12, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 2620 Hotel, 2620 Jones Street,
San Francisco, CA 94133.
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892, 301–402–4411, tianbi@csr.nih.gov.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
2875
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–213:
Outcome Measures for Use in Treatment
Trials for Individuals with Intellectual and
Developmental Disabilities.
Date: February 11, 2016.
Time: 8:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Jane A. DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: February 11–12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Marc Boulay, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 300–
6541, boulaymg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Nursing and
Related Clinical Sciences Overflow.
Date: February 11–12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington DC, 923
16th Street N.W., Washington, DC 20006.
Contact Person: Martha L. Hare, Ph.D., RN,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154,
Bethesda, MD 20892, (301) 451–8504,
harem@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–137:
Bioengineering Research.
Date: February 11, 2016.
Time: 8:00 a.m. to 9:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
N.W., Washington, DC 20037.
Contact Person: Yvonne Bennett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199,
MSC 7846, Bethesda, MD 20892, 301–379–
3793, bennetty@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interventions to Prevent and Treat
Addictions.
Date: February 11, 2016.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue N.W., Washington, DC
20036.
E:\FR\FM\19JAN1.SGM
19JAN1
2876
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, (301) 594–
3292, niw@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–00794 Filed 1–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Requirements and
Registration for ‘‘Pill Image
Recognition Challenge’’
Authority: 15 U.S.C. 3719
The Pill Image Recognition
Challenge is a National Institutes of
Health (NIH) Challenge under the
America COMPETES (Creating
Opportunities to Meaningfully Promote
Excellence in Technology, Education,
and Science) Reauthorization Act of
2010 (Pub. L. 111–358). Through this
Challenge, the National Library of
Medicine (NLM), part of NIH, seeks
algorithms and software to match
images of prescription oral solid-dose
pharmaceutical medications (pills,
including capsules and tablets). The
objective of the Challenge is the
development and discovery of highquality algorithms and software that
rank how well consumer images of
prescription pills match reference
images of pills in the authoritative NLM
RxIMAGE database. NLM may use all or
part of any Challenge entry (i.e.,
algorithm and software) to create a
future software system and a future API
(Application Programming Interface) for
pill image recognition; the system will
be freely usable and the API will be
freely accessible.
DATES: NLM will make a set of
consumer-quality images and a
companion set of reference images
publicly available on January 15, 2016.
The Challenge begins January 19,
2016.
Submission period: April 4, 2016 to
May 31, 2016.
Judging period: June 6, 2016 to July
15, 2016.
Winners announced: August 1, 2016.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
Notifications of any
amendment to this Federal Register
notice and answers to frequently asked
questions about it will be posted at
https://pir.nlm.nih.gov/challenge/
notifications-and-FAQs. Submissions
must be mailed to: Pill Image
Recognition Challenge, Computational
Photography Project for Pill
Identification (C3PI), National Library of
Medicine, Building 38A, Room B1–N30,
8600 Rockville Pike, Bethesda, MD
20894.
ADDRESSES:
National Institutes of Health
SUMMARY:
Submissions received by NLM after
the submission period ends will not be
considered. A submission is considered
to meet the submission deadline if it is
received by May 31, 2016, 5:00 p.m.
EDT. While NLM plans to acknowledge
receipt of each Challenge submission,
the Government is under no obligation
to acknowledge receipt of the
information received or provide
feedback to respondents with respect to
any information submitted. NLM will
amend this Federal Register notice if
the timeline or the rules for the
Challenge are modified. In addition,
NLM will notify registered Challenge
participants by email of any
amendments and will include the
modified Challenge showing the
changes.
FOR FURTHER INFORMATION CONTACT:
Michael J. Ackerman, Ph.D. at (301)
402–4100 or PIR@nlm.nih.gov.
SUPPLEMENTARY INFORMATION:
The IC’s Statutory Authority To
Conduct the Challenge
What has become today’s National
Library of Medicine began in 1836 as a
small collection of medical books and
journals in the office of the U.S. Army
Surgeon General. A 1956 act of Congress
(Pub. L. 84–941) transferred the library
to the Public Health Service and gave it
its current name. That law authorizes
NLM to ‘‘assist the advancement of
medical and related sciences and to aid
the dissemination and exchange of
scientific and other information
important to the progress of medicine
and to the public health’’ and to
‘‘promote the use of computers and
telecommunications by health
professionals (including health
professionals in rural areas) for the
purpose of improving access to
biomedical information for health care
delivery and medical research.’’ In
addition to its subject-matter authority,
NLM is conducting this competition
under the America COMPETES
Reauthorization Act of 2010 (Pub. L.
111–358).
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Subject of Challenge
Unidentified and misidentified
prescription pills present challenges for
patients and professionals. Unidentified
pills can be found by family members,
health professionals, educators, and law
enforcement. The nine out of 10 U.S.
citizens over age 65 who take more than
one prescription pill can be prone to
misidentifying those pills. Taking such
pills can result in adverse drug events
that affect health or cause death. To
reduce such errors, any person should
easily be able to confirm that a
prescription pill or a refill is correct. For
example, a person should be able to
easily verify—or not—that a refill that
has a different color, shape, or text
imprinted on the pill is a different
generic version of equivalent drugs he
or she was already taking.
To help address these problems, the
NLM Computational Photography
Project for Pill Identification (C3PI) is
developing infrastructure and tools for
identifying prescription pills. The
infrastructure includes photographs of
such pills taken under laboratory
lighting conditions, from a camera
directly above the front and the back
faces of the pill, and at high resolution.
Specialized digital macro-photography
techniques were then used to capture
JPEG pill images. The NLM RxIMAGE
database contains these high-quality
images and associated pill data such as
appearance (color, shape, size, text
imprinted on the pill, etc.), ingredients,
and identifiers such as its National Drug
Code (NDC) [https://www.fda.gov/Drugs/
InformationOnDrugs/ucm142438.htm].
RxIMAGE images and data are freely
available. The freely accessible
RxIMAGE API provides text-based
search and retrieval of images and data
from the RxIMAGE database. By
contributing their algorithm and
software, Challenge participants will
take part in a broader NLM effort to
develop a freely usable software system
and a freely accessible API for imagebased search and retrieval from a mobile
device.
In a typical scenario for a future NLM
mobile app, a person will download the
app and use it to photograph a
prescription pill, possibly under poor
lighting conditions, from an angle, or at
low resolution. The future app will
communicate with the future pill image
recognition software system, which may
use all or part of any Challenge entry,
to compare that photo to reference
images in the RxIMAGE database, and
will return one or more reference images
that most likely match the photographed
pill along with their associated pill data.
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Pages 2875-2876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00794]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Auditory Neuroscience.
Date: February 2-3, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Biomedical Computing and Health Informatics
Study Section.
Date: February 5, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101.
Contact Person: Peter J. Kozel, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892, 301-
435-1116, kozelp@mail.nih.gov.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Instrumentation and Systems Development
Study Section.
Date: February 10-11, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Best Western Tuscan Inn, 425 North Point Street, San
Francisco, CA 94133.
Contact Person: Kathryn Kalasinsky, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158 MSC 7806, Bethesda, MD
20892, 301-402-1074, kalasinskyks@mail.nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Surgery, Anesthesiology and
Trauma Study Section.
Date: February 10-11, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton San Diego Mission Valley, 901 Camino Del Rio
South, San Diego, CA 92108.
Contact Person: Weihua Luo, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, (301) 435-1170, luow@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Motor Function, Speech and Rehabilitation
Study Section.
Date: February 11-12, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 2620 Hotel, 2620 Jones Street, San Francisco, CA
94133.
Contact Person: Biao Tian, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3166, MSC 7848, Bethesda, MD 20892, 301-402-
4411, tianbi@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR13-213: Outcome Measures for Use in Treatment Trials for
Individuals with Intellectual and Developmental Disabilities.
Date: February 11, 2016.
Time: 8:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jane A. Doussard-Roosevelt, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: February 11-12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA
92101.
Contact Person: Marc Boulay, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 300-
6541, boulaymg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Nursing and Related Clinical Sciences Overflow.
Date: February 11-12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The St. Regis Washington DC, 923 16th Street N.W.,
Washington, DC 20006.
Contact Person: Martha L. Hare, Ph.D., RN, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154, Bethesda, MD 20892, (301)
451-8504, harem@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR13-137: Bioengineering Research.
Date: February 11, 2016.
Time: 8:00 a.m. to 9:00 a.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Washington DC, Dupont Circle, 1143 New
Hampshire Avenue N.W., Washington, DC 20037.
Contact Person: Yvonne Bennett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301-379-3793, bennetty@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Interventions to Prevent and Treat Addictions.
Date: February 11, 2016.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue
N.W., Washington, DC 20036.
[[Page 2876]]
Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD
20892, (301) 594-3292, niw@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-00794 Filed 1-15-16; 8:45 am]
BILLING CODE 4140-01-P
